Stephens & Co. Reiterates Overweight on Staar Surgical, Maintains $57 Price Target
Portfolio Pulse from richadhand@benzinga.com
Stephens & Co. analyst George Sellers has reiterated an Overweight rating on Staar Surgical (NASDAQ:STAA) and maintained a $57 price target.
August 14, 2023 | 12:11 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Staar Surgical's stock rating has been reiterated as Overweight by Stephens & Co. with a maintained price target of $57.
The reiteration of an Overweight rating by Stephens & Co. indicates their positive outlook on Staar Surgical. This could potentially attract investors, driving the stock price up in the short term. The maintained price target of $57 also suggests that the analyst believes the stock is currently undervalued.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100